| Carly Boyum, | |
|
102 6th St Se, Hankinson, ND 58041-4200 | |
| (701) 242-7031 | |
| Not Available |
| Full Name | Carly Boyum |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 102 6th St Se, Hankinson, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578139937 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1951 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carly Boyum, Po Box 100, Hankinson, ND 58041-0100 Ph: (701) 242-7031 | Carly Boyum, 102 6th St Se, Hankinson, ND 58041-4200 Ph: (701) 242-7031 |
News Archive
Two new studies have found that smokers who tend to take their first cigarette soon after they wake up in the morning may have a higher risk of developing lung and head and neck cancers than smokers who refrain from lighting up right away.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that patient access to premium-priced targeted cancer treatments in Brazil and Mexico is improving, creating an opportunity for developers and marketers of epidermal growth factor receptor (EGFR) inhibitors.
The newly launched Pulmonary Fibrosis Foundation Patient Communication Center (PCC) has become the destination for the most up-to-date information for the pulmonary fibrosis community. The PCC now has information about the Expanded Access Program (EAP) for pirfenidone.
Ipsen, an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed headline results of the fourth and fifth of eight T-emerge phase III studies in patients with diabetes for taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence.
Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce that Ranbaxy Laboratories Limited (Ranbaxy) has purchased the Provantis preclinical software suite to automate laboratory processes at their R&D Headquarters in Gurgaon, India.
› Verified 9 days ago
Ashley Marie Vig, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 6th St. Se, Hankinson, ND 58041 Phone: 701-242-7031 Fax: 701-242-8202 | |
Cheryl R. Krivarchka, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 6th St Se, Hankinson, ND 58041 Phone: 701-242-7031 | |
Stephanie Rayamajhee, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 6th St Se, Hankinson, ND 58041 Phone: 701-242-7031 | |
Deanna M Prante, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 6th St Se, Hankinson, ND 58041 Phone: 701-242-7031 | |
Tracey R. Froemke, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 6th St Se, Hankinson, ND 58041 Phone: 701-242-7031 | |
Jennifer Kath, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 6th St Se, Hankinson, ND 58041 Phone: 701-242-7031 |